Thinking outside the triangle: Replication fidelity of the largest RNA viruses

Annual Review of Virology

Volumn 1, Issue 1, 2014, Pages 111-132

  Smith, Everett Clinton ^a   Sexton, Nicole R ^a   Denison, Mark R ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Coronavirus; Exoribonuclease; Proofreading; Quasispecies; Virus evolution

Indexed keywords

DNA POLYMERASE; EXORIBONUCLEASE; FLUOROURACIL; LIVE VACCINE; RIBAVIRIN; RNA; RNA DIRECTED RNA POLYMERASE; RNA POLYMERASE; VIRUS PROTEIN; VIRUS RNA;

ANTIVIRAL ACTIVITY; ARBOVIRUS; ARTERIVIRIDAE; ARTICLE; CELLULAR ORGANISM; COMMON COLD; CORONAVIRIDAE; DNA VIRUS; GENETIC VARIABILITY; GENOME ANALYSIS; GENOME SIZE; GENOMIC INSTABILITY; HUMAN; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; MOLECULAR EVOLUTION; NIDOVIRALES; PATHOGENESIS; PICORNAVIRIDAE; PRIORITY JOURNAL; RNA REPLICATION; RNA SYNTHESIS; RNA VIRUS; VIRUS CELL INTERACTION; VIRUS GENOME; VIRUS REPLICATION; VIRUS STRAIN;

CORONAVIRUS; RNA VIRUSES;

EID: 85016934946     PISSN: 2327056X     EISSN: 23270578     Source Type: Journal    
DOI: 10.1146/annurev-virology-031413-085507     Document Type: Article

References (122)

1. Eigen M. 1971. Selforganization of matter and the evolution of biological macromolecules. Naturwissenschaften 58:465-523
2. Sanjuán R, Nebot MR, Chirico N, Mansky LM, Belshaw R. 2010. Viral mutation rates. J. Virol. 84:9733-48
3. Bradwell K, Combe M, Domingo-Calap P, Sanjuán R. 2013. Correlation between mutation rate and genome size in riboviruses: mutation rate of bacteriophage Qβ. Genetics 195:243-51
4. Graham RL, Donaldson EF, Baric RS. 2013. A decade after SARS: strategies for controlling emerging coronaviruses. Nat. Rev. Microbiol. 11:836-48
5. Ge XY,Li JL, Yang XL,Chmura AA, ZhuG, et al. 2013. Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor. Nature 503:535-38
6. Huynh J, Li S, Yount B, Smith A, Sturges L, et al. 2012. Evidence supporting a zoonotic origin of human coronavirus strain NL63. J. Virol. 86:12816-25
7. Pfefferle S, Oppong S, Drexler JF, Gloza-Rausch F, Ipsen A, et al. 2009. Distant relatives of severe acute respiratory syndrome coronavirus and close relatives of human coronavirus 229E in bats, Ghana. Emerg. Infect. Dis. 15:1377-84
8. Crossley BM, Mock RE, Callison SA, Hietala SK. 2012. Identification and characterization of a novel alpaca respiratory coronavirus most closely related to the human coronavirus 229E. Viruses 4:3689-700
9. Vijgen L, Keyaerts E, Moës E, Thoelen I, Wollants E, et al. 2005. Complete genomic sequence of human coronavirus OC43: molecular clock analysis suggests a relatively recent zoonotic coronavirus transmission event. J. Virol. 79:1595-604
10. Woo PCY, Lau SKP, Huang Y, Tsoi HW, Chan KH, Yuen KY. 2005. Phylogenetic and recombination analysis of coronavirus HKU1, a novel coronavirus from patients with pneumonia. Arch. Virol. 150:2299-311
11. Peiris JSM, Lai ST, Poon LLM, Guan Y, Yam LYC, et al. 2003. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 361:1319-25
12. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus ADME, Fouchier RAM. 2012. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N. Engl. J. Med. 367:1814-20
13. Woo PCY, Lau SKP, Huang Y, Yuen KY. 2009. Coronavirus diversity, phylogeny and interspecies jumping. Exp. Biol. Med. 234:1117-27
14. Drexler JF, Corman VM, Drosten C. 2013. Ecology, evolution and classification of bat coronaviruses in the aftermath of SARS. Antivir. Res. 101:45-56
15. Wertheim JO, Chu DKW, Peiris JSM, Kosakovsky Pond SL, Poon LLM. 2013. A case for the ancient origin of coronaviruses. J. Virol. 87:7039-45
16. Calisher CH, Childs JE, Field HE, Holmes KV, Schountz T. 2006. Bats: important reservoir hosts of emerging viruses. Clin. Microbiol. Rev. 19:531-45
17. Hilgenfeld R, Peiris M. 2013. From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses. Antivir. Res. 100:286-95
18. Haagmans BL,AlDhahiry SHS, ReuskenCBEM, RajVS, GalianoM, et al. 2013. MiddleEast respiratory syndrome coronavirus in dromedary camels: an outbreak investigation. Lancet Infect. Dis. 14:140-45
19. Alagaili AN, Briese T,MishraN, Kapoor V, Sameroff SC, et al. 2014. Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia. mBio 5:e00884-14
20. Cauchemez S, Fraser C, Van Kerkhove MD, Donnelly CA, Riley S, et al. 2014. Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility. Lancet Infect. Dis. 14:50-56
21. Breban R, Riou J, Fontanet A. 2013. Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk. Lancet 382:694-99
22. Perlman S, Netland J. 2009. Coronaviruses post-SARS: update on replication and pathogenesis. Nat. Rev. Microbiol. 7:439-50
23. Brierley I, Boursnell ME, Binns MM, Bilimoria B, Blok VC, et al. 1987. An efficient ribosomal frameshifting signal in the polymerase-encoding region of the coronavirus IBV. EMBO J. 6:3779-85
24. Plant EP, Pérez-Alvarado GC, Jacobs JL, Mukhopadhyay B, Hennig M, Dinman JD. 2005. A threestemmed mRNA pseudoknot in the SARS coronavirus frameshift signal. PLoS Biol. 3:e172
25. Snijder EJ, Bredenbeek PJ, Dobbe JC, Thiel V, Ziebuhr J, et al. 2003. Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage. J. Mol. Biol. 331:991-1004
26. Ziebuhr J, Snijder EJ, Gorbalenya AE. 2000. Virus-encoded proteinases and proteolytic processing in the Nidovirales. J. Gen. Virol. 81:853-79
27. Wu HY, Brian DA. 2010. Subgenomic messenger RNA amplification in coronaviruses. Proc. Natl. Acad. Sci. USA 107:12257-62
28. Imbert I, Guillemot JC, Bourhis JM, Bussetta C, Coutard B, et al. 2006. A second, non-canonical RNAdependent RNA polymerase in SARS coronavirus. EMBO J. 25:4933-42
29. te Velthuis AJW, van denWorm SHE, Snijder EJ. 2012. The SARS-coronavirus nsp7+nsp8 complex is a unique multimeric RNA polymerase capable of both de novo initiation and primer extension. Nucleic Acids Res. 40:1737-47
30. te Velthuis AJW, Arnold JJ, Cameron CE, van den Worm SHE, Snijder EJ. 2010. The RNA polymerase activity of SARS-coronavirus nsp12 is primer dependent. Nucleic Acids Res. 38:203-14
31. Cheng A, Zhang W, Xie Y, JiangW, Arnold E, et al. 2005. Expression, purification, and characterization of SARS coronavirus RNA polymerase. Virology 335:165-76
32. Ahn DG, Choi JK, Taylor DR, Oh JW. 2012. Biochemical characterization of a recombinant SARS coronavirus nsp12 RNA-dependent RNA polymerase capable of copying viral RNA templates. Arch. Virol. 157:2095-104
33. Seybert A, Hegyi A, Siddell SG, Ziebuhr J. 2000. The human coronavirus 229E superfamily 1 helicase has RNA and DNA duplex-unwinding activities with 5'-to-3' polarity. RNA 6:1056-68
34. Ivanov KA, Ziebuhr J. 2004. Human coronavirus 229E nonstructural protein 13: characterization of duplex-unwinding, nucleoside triphosphatase, and RNA 5'-triphosphatase activities. J. Virol. 78:7833-38
35. Chen Y, Cai H, Pan J, Xiang N, Tien P, et al. 2009. Functional screen reveals SARS coronavirus nonstructural protein nsp14 as a novel cap N7 methyltransferase. Proc. Natl. Acad. Sci. USA 106:3484-89
36. Minskaia E, Hertzig T, Gorbalenya AE, Campanacci V, Cambillau C, et al. 2006. Discovery of an RNA virus 3'→5' exoribonuclease that is critically involved in coronavirus RNA synthesis. Proc. Natl. Acad. Sci. USA 103:5108-13
37. Ivanov KA, Hertzig T, Rozanov M, Bayer S, Thiel V, et al. 2004. Major genetic marker of nidoviruses encodes a replicative endoribonuclease. Proc. Natl. Acad. Sci. USA 101:12694-99
38. Decroly E, Imbert I, Coutard B, Bouvet M, Selisko B, et al. 2008. Coronavirus nonstructural protein 16 is a cap-0 binding enzyme possessing (nucleoside-2'O)-methyltransferase activity. J. Virol. 82:8071-84
39. Zhai Y, Sun F, Li X, Pang H, Xu X, et al. 2005. Insights into SARS-CoV transcription and replication from the structure of the nsp7-nsp8 hexadecamer. Nat. Struct. Mol. Biol. 12:980-86
40. Donaldson EF, Sims AC, Graham RL, Denison MR, Baric RS. 2007. Murine hepatitis virus replicase protein nsp10 is a critical regulator of viral RNA synthesis. J. Virol. 81:6356-68
41. Bouvet M, Debarnot C, Imbert I, Selisko B, Snijder EJ, et al. 2010. In vitro reconstitution of SARScoronavirus mRNA cap methylation. PLoS Pathog. 6:e1000863
42. Bouvet M, Imbert I, Subissi L, Gluais L, Canard B, Decroly E. 2012. RNA 3'-end mismatch excision by the severe acute respiratory syndrome coronavirus nonstructural protein nsp10/nsp14 exoribonuclease complex. Proc. Natl. Acad. Sci. USA 109:9372-77
43. Decroly E, Debarnot C, Ferron F, Bouvet M, Coutard B, et al. 2011. Crystal structure and functional analysis of the SARS-coronavirus RNA cap 2'-O-methyltransferase nsp10/nsp16 complex. PLoS Pathog. 7:e1002059
44. Chen Y, Su C, Ke M, Jin X, Xu L, et al. 2011. Biochemical and structural insights into the mechanisms of SARS coronavirus RNA ribose 2'-O-methylation by nsp16/nsp10 protein complex. PLoS Pathog. 7:e1002294
45. Xu X, Liu Y, Weiss S, Arnold E, Sarafianos SG, Ding J. 2003. Molecular model of SARS coronavirus polymerase: implications for biochemical functions and drug design. Nucleic Acids Res. 31:7117-30
46. Gorbalenya AE, Pringle FM, Zeddam JL, Luke BT, Cameron CE, et al. 2002. The palm subdomain-based active site is internally permuted in viral RNA-dependent RNA polymerases of an ancient lineage. J. Mol. Biol. 324:47-62
47. Fijalkowska IJ, Schaaper RM, Jonczyk P. 2012. DNA replication fidelity in Escherichia coli: a multi-DNA polymerase affair. FEMS Microbiol. Rev. 36:1105-21
48. Kunkel TA, Bebenek K. 2000. DNA replication fidelity. Annu. Rev. Biochem. 69:497-529
49. Kunkel TA. 2004. DNA replication fidelity. J. Biol. Chem. 279:16895-98
50. Drake JW. 1991. A constant rate of spontaneous mutation in DNA-based microbes. Proc. Natl. Acad. Sci. USA 88:7160-64
51. Cuevas JM, Domingo-Calap P, Pereira-G ómez M, Sanjuán R. 2009. Experimental evolution and population genetics of RNA viruses. Open Evol. J. 3:9-16
52. Johnson SJ, Beese LS. 2004. Structures of mismatch replication errors observed in a DNA polymerase. Cell 116:803-16
53. Sintim HO, Kool ET. 2006. Remarkable sensitivity to DNA base shape in the DNA polymerase active site. Angew. Chem. Int. Ed. Engl. 45:1974-79
54. Franklin MC, Wang J, Steitz TA. 2001. Structure of the replicating complex of a pol α family DNA polymerase. Cell 105:657-67
55. Castro C, Arnold JJ, Cameron CE. 2005. Incorporation fidelity of the viral RNA-dependent RNA polymerase: a kinetic, thermodynamic and structural perspective. Virus Res. 107:141-49
56. Cameron CE, Moustafa IM, Arnold JJ. 2009. Dynamics: the missing link between structure and function of the viral RNA-dependent RNA polymerase? Curr. Opin. Struct. Biol. 19:768-74
57. Moustafa IM, Shen H, Morton B, Colina CM, Cameron CE. 2011. Molecular dynamics simulations of viral RNA polymerases link conserved and correlated motions of functional elements to fidelity. J. Mol. Biol. 410:159-81
58. Yang X, Smidansky ED, Maksimchuk KR, Lum D, Welch JL, et al. 2012. Motif D of viral RNAdependentRNApolymerases determines efficiency and fidelity of nucleotide addition. Structure 20:1519-27
59. Steinhauer DA, Domingo E,Holland JJ. 1992. Lack of evidence for proofreadingmechanisms associated with an RNA virus polymerase. Gene 122:281-88
60. Drake JW, Holland JJ. 1999. Mutation rates among RNA viruses. Proc. Natl. Acad. Sci. USA 96:13910-13
61. Morrison A, Bell JB, Kunkel TA, Sugino A. 1991. Eukaryotic DNA polymerase amino acid sequence required for 3'→5' exonuclease activity. Proc. Natl. Acad. Sci. USA 88:9473-77
62. Schaaper RM, Radman M. 1989. The extreme mutator effect of Escherichia coli mutD5 results from saturation of mismatch repair by excessive DNA replication errors. EMBO J. 8:3511-16
63. McCulloch SD,KunkelTA. 2008. The fidelity ofDNAsynthesis by eukaryotic replicative and translesion synthesis polymerases. Cell Res. 18:148-61
64. Arnold JJ, Cameron CE. 2004. Poliovirus RNA-dependent RNA polymerase (3Dpol): pre-steady-state kinetic analysis of ribonucleotide incorporation in the presence of Mg2+. Biochemistry 43:5126-37
65. Gorbalenya AE, Enjuanes L, Ziebuhr J, Snijder EJ. 2006. Nidovirales: evolving the largest RNA virus genome. Virus Res. 117:17-37
66. Smith EC, Blanc H, Vignuzzi M, Denison MR. 2013. Coronaviruses lacking exoribonuclease activity are susceptible to lethal mutagenesis: evidence for proofreading and potential therapeutics. PLoS Pathog. 9:e1003565
67. Eckerle LD, Lu X, Sperry SM, Choi L, Denison MR. 2007. High fidelity of murine hepatitis virus replication is decreased in nsp14 exoribonuclease mutants. J. Virol. 81:12135-44
68. Eckerle LD, Becker MM, Halpin RA, Li K, Venter E, et al. 2010. Infidelity of SARS-CoV nsp14-exonuclease mutant virus replication is revealed by complete genome sequencing. PLoS Pathog. 6:e1000896
69. Graham RL, Becker MM, Eckerle LD, BollesM, Denison MR, Baric RS. 2012. A live, impairedfidelity coronavirus vaccine protects in an aged, immunocompromised mouse model of lethal disease. Nat. Med. 18:1820-26
70. Mokili JL, Rohwer F, Dutilh BE. 2012. Metagenomics and future perspectives in virus discovery. Curr. Opin. Virol. 2:63-77
71. Lauring AS, Andino R. 2010. Quasispecies theory and the behavior of RNA viruses. PLoS Pathog. 6:e1001005
72. Domingo E, Sheldon J, Perales C. 2012. Viral quasispecies evolution. Microbiol. Mol. Biol. Rev. 76:159-216
73. Ojosnegros S, Perales C,Mas A, Domingo E. 2011. Quasispecies as a matter of fact: viruses and beyond. Virus Res. 162:203-15
74. Vignuzzi M, Stone JK, Arnold JJ, Cameron CE, Andino R. 2006. Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population. Nature 439:344-48
75. Lauring AS, Frydman J, Andino R. 2013. The role of mutational robustness in RNA virus evolution. Nat. Rev. Microbiol. 11:327-36
76. Gnädig NF, Beaucourt S, Campagnola G, Bordería AV, Sanz-Ramos M, et al. 2012. Coxsackievirus B3 mutator strains are attenuated in vivo. Proc. Natl. Acad. Sci. USA 109:E2294-303
77. Furi ó V, Moya A, Sanjuán R. 2005. The cost of replication fidelity in an RNA virus. Proc. Natl. Acad. Sci. USA 102:10233-37
78. Elena SF, Sanjuán R. 2005. Adaptive value of high mutation rates of RNA viruses: separating causes from consequences. J. Virol. 79:11555-58
79. Lee CH, Gilbertson DL, Novella IS, Huerta R, Domingo E, Holland JJ. 1997. Negative effects of chemical mutagenesis on the adaptive behavior of vesicular stomatitis virus. J. Virol. 71:3636-40
80. Pfeiffer JK, KirkegaardK. 2005. Increased fidelity reduces poliovirus fitness and virulence under selective pressure in mice. PLoS Pathog. 1:e11
81. Vignuzzi M, Wendt E, Andino R. 2008. Engineering attenuated virus vaccines by controlling replication fidelity. Nat. Med. 14:154-61
82. Regoes RR, Hamblin S, Tanaka MM. 2013. Viral mutation rates: modelling the roles of within-host viral dynamics and the trade-off between replication fidelity and speed. Proc. R. Soc. B 280:20122047
83. Schaaper RM. 1998. Antimutator mutants in bacteriophage T4 and Escherichia coli. Genetics 148:1579-85
84. MuzyczkaN, Poland RL, BessmanMJ. 1972. Studies on the biochemical basis of spontaneous mutation. I. A comparison of the deoxyribonucleic acid polymerases of mutator, antimutator, and wild type strains of bacteriophage T4. J. Biol. Chem. 247:7116-22
85. Gillin FD, Nossal NG. 1976. Control of mutation frequency by bacteriophage T4 DNA polymerase. I. The CB120 antimutator DNA polymerase is defective in strand displacement. J. Biol. Chem. 251:5219-24
86. Pfeiffer JK, Kirkegaard K. 2003. A single mutation in poliovirus RNA-dependent RNA polymerase confers resistance to mutagenic nucleotide analogs via increased fidelity. Proc. Natl. Acad. Sci. USA 100:7289-94
87. Coffey LL, Beeharry Y, Borderia AV, Blanc H, Vignuzzi M. 2011. Arbovirus high fidelity variant loses fitness in mosquitoes and mice. Proc. Natl. Acad. Sci. USA 108:16038-43
88. Harrison DN, Gazina EV, Purcell DF, Anderson DA, Petrou S. 2008. Amiloride derivatives inhibit coxsackievirus B3 RNA replication. J. Virol. 82:1465-73
89. Arnold JJ, Vignuzzi M, Stone JK, Andino R, Cameron CE. 2005. Remote site control of an active site fidelity checkpoint in a viral RNA-dependent RNA polymerase. J. Biol. Chem. 280:25706-16
90. Rozen-Gagnon K, Stapleford KA, Mongelli V, Blanc H, Failloux AB, et al. 2014. Alphavirus mutator variants present host-specific defects and attenuation in mammalian and insect models. PLoS Pathog. 10:e1003877
91. Zeng J, Wang H, Xie X, Yang D, Zhou G, Yu L. 2013. An increased replication fidelity mutant of foot-and-mouth disease virus retains fitness in vitro and virulence in vivo. Antivir. Res. 100:1-7
92. Zeng J, Wang H, Xie X, Li C, Zhou G, et al. 2014. Ribavirin-resistant variants of foot-and-mouth disease virus: the effect of restricted quasispecies diversity on viral virulence. J. Virol. 88:4008-20
93. Liu X, Yang X, Lee CA,Moustafa IM, Smidansky ED, et al. 2013. Vaccine-derived mutation in motif D of poliovirus RNA-dependent RNA polymerase lowers nucleotide incorporation fidelity. J. Biol. Chem. 288:32753-65
94. Sadeghipour S, McMinn PC. 2013. A study of the virulence in mice of high copying fidelity variants of human enterovirus 71. Virus Res. 176:265-72
95. Sadeghipour S, Bek EJ, McMinn PC. 2013. Ribavirin-resistant mutants of human enterovirus 71 express a high replication fidelity phenotype during growth in cell culture. J. Virol. 87:1759-69
96. Weeks SA, Lee CA, Zhao Y, Smidansky ED, August A, et al. 2012. A polymerase mechanism-based strategy for viral attenuation and vaccine development. J. Biol. Chem. 287:31618-22
97. Arias A, Arnold JJ, Sierra M, Smidansky ED, Domingo E, Cameron CE. 2008. Determinants of RNAdependent RNA polymerase (in)fidelity revealed by kinetic analysis of the polymerase encoded by a foot-and-mouth disease virus mutant with reduced sensitivity to ribavirin. J. Virol. 82:12346-55
98. Levi LI, Gnädig NF, Beaucourt S, McPherson MJ, Baron B, et al. 2010. Fidelity variants of RNA dependent RNA polymerases uncover an indirect, mutagenic activity of amiloride compounds. PLoS Pathog. 6:e1001163
99. Sierra M, Airaksinen A, González-López C, Agudo R, Arias A, Domingo E. 2007. Foot-and-mouth disease virus mutant with decreased sensitivity to ribavirin: implications for error catastrophe. J. Virol. 81:2012-24
100. Nga PT, Parquet MDC, Lauber C, Parida M, Nabeshima T, et al. 2011. Discovery of the first insect nidovirus, a missing evolutionary link in the emergence of the largest RNA virus genomes. PLoS Pathog. 7:e1002215
101. Zirkel F, Kurth A, Quan PL, Briese T, Ellerbrok H, et al. 2011. An insect nidovirus emerging from a primary tropical rainforest. mBio 2:e00077-11
102. Zuo Y, DeutscherMP. 2001. Exoribonuclease superfamilies: structural analysis and phylogenetic distribution. Nucleic Acids Res. 29:1017-26
103. Chen Y, Tao J, Sun Y, Wu A, Su C, et al. 2013. Structure-function analysis of severe acute respiratory syndrome coronavirus RNA cap guanine-N7-methyltransferase. J. Virol. 87:6296-305
104. Smith EC, Denison MR. 2013. Coronaviruses as DNA wannabes: a new model for the regulation of RNA virus replication fidelity. PLoS Pathog. 9:e1003760
105. Hastie KM, Kimberlin CR, Zandonatti MA, MacRae IJ, Saphire EO. 2011. Structure of the Lassa virus nucleoprotein reveals a dsRNA-specific 3' to 5' exonuclease activity essential for immune suppression. Proc. Natl. Acad. Sci. USA 108:2396-401
106. Huang C, Lokugamage KG, Rozovics JM,Narayanan K, Semler BL,Makino S. 2011. SARS coronavirus nsp1 protein induces template-dependent endonucleolytic cleavage ofmRNAs: viralmRNAsare resistant to nsp1-induced RNA cleavage. PLoS Pathog. 7:e1002433
107. Shi X, Wang L, Li X, Zhang G, Guo J, et al. 2011. Endoribonuclease activities of porcine reproductive and respiratory syndrome virus nsp11 was essential for nsp11 to inhibit IFN-βinduction. Mol. Immunol. 48:1568-72
108. Frieman M, Ratia K, Johnston RE, Mesecar AD, Baric RS. 2009. Severe acute respiratory syndrome coronavirus papain-like protease ubiquitin-like domain and catalytic domain regulate antagonism of IRF3 and NF-κB signaling. J. Virol. 83:6689-705
109. Kun A, Santos M, Szathmáry E. 2005. Real ribozymes suggest a relaxed error threshold. Nat. Genet. 37:1008-11
110. Smith JM. 1979. Hypercycles and the origin of life. Nature 280:445-46
111. Lauber C, Goeman JJ, Parquet MDC, Nga PT, Snijder EJ, et al. 2013. The footprint of genome architecture in the largest genome expansion in RNA viruses. PLoS Pathog. 9:e1003500
112. von Brunn A, Teepe C, Simpson JC, Pepperkok R, Friedel CC, et al. 2007. Analysis of intraviral proteinprotein interactions of the SARS coronavirus ORFeome. PLoS ONE 2:e459
113. Pan J, Peng X, Gao Y, Li Z, Lu X, et al. 2008. Genome-wide analysis of protein-protein interactions and involvement of viral proteins in SARS-CoV replication. PLoS ONE 3:e3299
114. Imbert I, Snijder EJ, Dimitrova M, Guillemot JC, Lécine P, Canard B. 2008. The SARS-coronavirus PLnc domain of nsp3 as a replication/transcription scaffolding protein. Virus Res. 133:136-48
115. Subissi L, Imbert I, Ferron F,ColletA,CoutardB, et al. 2013. SARS-CoV ORF1b-encoded nonstructural proteins 12-16: replicative enzymes as antiviral targets. Antivir. Res. 101:122-30
116. Johansson E, Dixon N. 2013. Replicative DNA polymerases. Cold Spring Harb. Perspect. Biol. 5:a012799
117. Studwell-Vaughan PS, O'Donnell M. 1993. DNA polymerase III accessory proteins. V. θ encoded by holE. J. Biol. Chem. 268:11785-91
118. Taft-Benz SA, Schaaper RM. 2004. The θ subunit of Escherichia coli DNA polymerase III: a role in stabilizing the ε proofreading subunit. J. Bacteriol. 186:2774-80
119. Sawicki D, Wang T, Sawicki S. 2001. The RNA structures engaged in replication and transcription of the A59 strain of mouse hepatitis virus. J. Gen. Virol. 82:385-96
120. Zhuang Z, Ai Y. 2010. Processivity factor of DNA polymerase and its expanding role in normal and translesion DNA synthesis. Biochim. Biophys. Acta 1804:1081-93
121. Züst R, Cervantes-Barragan L, HabjanM,Maier R, Neuman BW, et al. 2011. Ribose 2'-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5. Nat. Immunol. 12:137-43
122. Egloff MP, Ferron F, Campanacci V, Longhi S, Rancurel C, et al. 2004. The severe acute respiratory syndrome-coronavirus replicative protein nsp9 is a single-stranded RNA-binding subunit unique in the RNA virus world. Proc. Natl. Acad. Sci. USA 101:3792-96